Won the Grand Prize in the International Category at “TOKYO SUTEAM DEMO DAY 2026”

FerroptoCure Co., Ltd. (Representative Director: Yuji Otsuki) won the Grand Prize in the International Category at the “TOKYO SUTEAM DEMO DAY 2026” startup contest held in March 2026.

TOKYO SUTEAM is a startup support initiative promoted by the Tokyo Metropolitan Government. It collaborates with a diverse range of support organizations to foster the creation and growth of startups active both domestically and internationally. “TOKYO SUTEAM DEMO DAY” is an event held to showcase the results of these efforts, where outstanding startups are recognized in the Founding, Growth, and International categories based on criteria such as future potential, business viability, and social impact.

In receiving this award, FerroptoCure was recognized for its unique drug discovery technology, its business strategy focused on the global market, the feasibility of its international expansion, and its challenge to develop a world-first drug.
Furthermore, the company’s initiatives aimed at overseas research and development and business expansion, as well as its strategies for building international partnerships, were highly praised.

FerroptoCure will continue to advance the research and development of innovative cancer therapies targeting ferroptosis, while deepening collaborations with domestic and international companies and research institutions to bring these innovative treatments to market.
We remain committed to drug discovery and development so that we can continue to provide new treatment options to patients around the world.

関連記事：TOKYO SUTEAM DEMO DAY 2026 海外部門最優秀賞 FerroptoCure | NIKKEI THE PITCH
関連ページ　CEO message 　Science